Chelsea and Westminster Hospital pioneers autonomous artificial intelligence (AI) pathway for skin cancer to discharge harmless cases
Posted:
Chelsea and Westminster Hospital NHS Foundation Trust is utilising digital innovation and world-first autonomous technology to identify harmless (benign) skin lesions without review from the dermatology team, to be able to discharge patients on the same day as they receive their results.
This advanced AI skin cancer pathway helps clinicians and dermatologists effectively triage patients, enabling earlier detection.
The GIANT Health Event 2026 is the UK’s leading healthcare innovation festival, bringing together NHS leaders, clinicians, innovators, investors, and health-tech pioneers for two days of collaboration, discovery, and transformation.
If you’re attending this year, planning your visit in advance…
Every year, GIANT Health brings together the organisations actively shaping the future of healthcare — from NHS trusts and research bodies to global technology companies, regulatory experts, and fast-growing health-tech innovators.
The strength of the event lies not only in…